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Feline coronavirus (FCoV) is endemic in feral cat pop-
ulations and cat colonies, frequently preceding outbreaks 
of fatal feline infectious peritonitis (FIP). FCoV exhibits 2 
biotypes: the pathogenic disease and a benign infection 
with feline enteric coronavirus (FECV). Uncertainty remains 
regarding whether genetically distinctive avirulent and viru-
lent forms coexist or whether an avirulent form mutates in 
vivo, causing FIP. To resolve these alternative hypotheses, 
we isolated viral sequences from FCoV-infected clinically 
healthy and sick cats (8 FIP cases and 48 FECV-asymptom-
atic animals); 735 sequences from 4 gene segments were 
generated and subjected to phylogenetic analyses. Viral 
sequences from healthy cats were distinct from sick cats on 
the basis of genetic distances observed in the membrane 
and nonstructural protein 7b genes. These data demon-
strate distinctive circulating virulent and avirulent strains in 
natural populations. In addition, 5 membrane protein amino 
acid residues with functional potential differentiated healthy 
cats from cats with FIP. These findings may have potential 
as diagnostic markers for virulent FIP-associated FCoV.  
Feline infectious peritonitis (FIP) is an uncommon, fatal, progressive, and immune-augmented disease of cats 
caused by feline coronavirus (FCoV) infection. Although 
FCoV is common in most domestic, feral, and nondomestic 
cat populations worldwide (seroprevalence 20%–100%), 
FIP will develop in <10% of FCoV seropositive cats (1–4). 
FIP tends to occur most frequently in cats <2 years of age 
or, less commonly, in geriatric cats (4,5). The clinical man-
ifestations of FCoV infection can be either a pathogenic 
disease, FIP (cases infected with feline infectious perito-
nitis virus [FIPV]) and, more commonly, a benign, or mild 
enteric infection (feline enteric coronavirus [FECV] as-
ymptomatic) (6,7). Specific genetic determinants of these 
clinical outcomes have yet to be discovered. There is no 
effective treatment, vaccine, or diagnostic protocol that can 
discriminate the avirulent FECV from FIPV.
FIP pathology is characterized typically by severe 
systemic inflammatory damage of serosal membranes and 
widespread pyogranulomatous lesions, which occurs in the 
lungs, liver, lymph tissue, and brain (8). Evidence suggests 
that the host immune system is crucial in this pathogenesis; 
profound T-cell depletion from the periphery and lymphatic 
tissues and changes in cytokine expression are observed in 
end-stage FIP (9,10). The clinical finding of hypergamma-
globulinemia-associated FIP is indicative of virus-induced 
immune dysregulation (11).
Viral genetic determinants specifically associated with 
FIPV pathogenesis have yet to be discovered. An in vivo 
mutation transition hypothesis postulated that de novo virus 
mutation occurs in vivo, giving rise to virulence (12,13). The 
precise nature of the mutation responsible for pathogenesis 
has not been identified, although studies have suggested se-
quence differences in the spike protein (14), nonstructural 
protein (NSP) 7b, and NSP3c (13) as disease determinants. 
Together with in vitro studies describing the FIPV strains 
affinity for macrophages in contrast to FECV strains (15), 
the hypothesis was extended to propose that the enteric coro-
navirus (FECV) undergoes a mutational shift in the gastroin-
testinal system, thus allowing infection of macrophages, sys-
temic dissemination, and fatal disease manifestation (12,13). 
However, attempts to use engineered chimeric viruses de-
signed to identify the operative virulence determinants have 
been unsuccessful (16). Furthermore, circulating FCoVs 
found in different tissues of FCoV-infected asymptomatic 
cats were indistinguishable (17,18).
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The in vivo mutation hypothesis of FIPV pathogen-
esis is widely cited, although it has never been explicitly 
confirmed. Mutational transition of HIV-1 has been dem-
onstrated in AIDS patients, in which mutation of envelope 
residues alters coreceptor use from CCR5 to CXCR4, a 
prelude to the collapse of the CD4-bearing lymphocyte 
population (19). Similarly, key amino acid changes in the 
porcine coronavirus spike gene lead to increased virulence 
in the coronavirus transmissible gastroenteritis virus, a fa-
tal disease causing high rates of illness and death in young 
pigs (20–22).
An alternative circulating virulent-avirulent FCoV hy-
pothesis of viral pathogenesis suggests that distinctive be-
nign and pathogenic strains of FECV circulate in a popula-
tion, and that the disease will develop only in those persons 
infected by the virulent strains. Dengue virus may offer an 
example because it has been shown that 4 distinctive viral 
strains circulate worldwide, and severe hemorrhagic fever 
develops in persons exposed sequentially to distinct strains 
(23). Zoonotic equine Venezuelan encephalitis virus also 
displays circulating virulent and avirulent strains, which 
through interaction with ecologic and epidemiologic fac-
tors, contribute to or constrain the disease incidence (24).
This study aimed to systematically test evolutionary 
predictions of the in vivo mutation hypothesis versus the 
circulating virulent/avirulent hypothesis in the pathogenic-
ity of FIP in the cat. We developed a study of naturally 
occurring FECV and FIPV using molecular genetic tools 
by collecting samples from field cases of FIP (cases) and 
FECV-positive but asymptomatic cats (controls). Cases 
were infected with feline coronavirus (FCoV) and had the 
clinical disease of feline infectious peritonitis (FIP). Con-
trols were also infected with FCoV, but were clinically 
asymptomatic (FECV-asymptomatic). The prediction was 
that phylogenetic analysis of viral gene sequences would 
demonstrate paraphyly for FIP case-cats and FECV-asymp-
tomatic cats if the in vivo mutation hypothesis was sup-
ported, and monophyly of the 2 if the circulating virulent/
avirulent hypothesis was supported (Figure 1). Addition-
ally, we surveyed the viral genetic diversity and dynamics 




A total of 56 live, euthanized, or recently deceased 
domestic cats were clinically examined and sampled in 
Maryland veterinary hospitals during 2004–2006 (online 
Appendix Table 1, available from www.cdc.gov/EID/
content/15/9/1445-appT1.htm). Blood (3–6 mL) was col-
lected routinely by venipuncture from manually restrained 
or anesthetized domestic cats. Feces were obtained from the 
rectum by cotton swab and frozen in 0.5 mL of phosphate-
buffered saline. Cats from 1 (Weller Farm) of 6 farms were 
micro-chipped (AVID, Folsom, LA, USA) for identifica-
tion for repeat sampling of individual cats. Samples were 
collected in full compliance with specific federal permits 
(Convention on International Trade in Endangered Species; 
Endangered and Threatened Species) issued to the National 
Cancer Institute by the US Fish and Wildlife Service of the 
Department of the Interior.
For euthanized and recently deceased cats, gross 
necropsy examination and sample collection were per-
formed within 2 hours of death. Samples from liver, spleen, 
mesenteric lymph node, kidney, jejunum, and colon were 
taken, fixed in 10% buffered formalin, and routinely em-
bedded in paraffin. Sections (5 μm) were stained with he-
matoxylin and eosin (HE). Tissues were also flash frozen in 
liquid nitrogen (–220°C) for RNA extraction and stored at 
either –220°C or –70C°.
Clinical Hematologic and Biochemical Analysis
For complete blood counts, fresh (<12 hours) whole-
blood samples were assessed by Antech veterinary di-
agnostic laboratory by using an automated cell counter 
(Avid Cell-Dyn 3500; Abbott Laboratories, Abbott Park, 
IL, USA). Biochemical analysis (Hitachi 717 Clinical 
Chemistry Analyzer; Roche Diagnostics, Indianapolis, IN, 
USA) and ELISA for feline immunodeficiency virus (FIV; 
Petchek FIV ELISA, Idexx Laboratories, Westbrook, ME, 
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Figure 1. Alternative phylogenetic predictions of the in vivo mutation 
hypothesis versus the dual circulating virulent/avirulent hypothesis. 
A) The in vivo mutation transition hypothesis predicts paraphyly of 
feline infectious peritonitis (FIP) cases and feline enteric coronavirus 
(FECV) asymptomatic feline coronavirus (FCoV) isolates). B) The 
circulating virulent/avirulent strain hypothesis predicts reciprocal 
monophyly of FIV-cases versus FECV asymptomatic. Numbers 
represent individual cat (or locale), which is either FIPV case (red) 
or FECV asymptomatic (blue). Evidence presented in this article 
supports the circulating dual virulent and avirulent strains.
Feline Infectious Peritonitis Virus
USA), and coronavirus (Virachek CV, Synbiotics Corp., 
San Diego, CA, USA) antibodies were also performed.
Pathologic and Immunohistochemical Analysis
HE-stained  slides of spleen, liver, lymph node, intes-
tine, and kidney sections were evaluated for evidence of 
granulomatous and pyogranulomatous lesions (National 
Cancer Institute Laboratory Animal Sciences Program, 
Frederick, MD, USA). Formalin-fixed sections (3 μm 
thick) were cut from paraffin blocks and placed on glass 
slides for immunohistochemical (IHC) testing, as previous-
ly described, with CoV p56, a cross-reacting antibody for 
the demonstration of feline coronavirus (FECV and FIPV 
biotypes) (9,10) (Washington Animal Disease Diagnostic 
Laboratory, Pullman, WA, USA) (Figure 2).
RNA Extraction and Reverse Transcription
RNA from 160 μL ascites fluid or frozen feces sus-
pended 10% in phosphate-buffered saline was extracted by 
using the QIAamp virus RNA mini kit (QIAGEN, Valen-
cia, CA, USA) following the manufacturer’s instructions. 
RNA from tissue was extracted from ≈60 mg of frozen 
liver, lung, spleen, colon, jejunum, or lymph node by using 
RNAeasy (QIAGEN) following the manufacturer’s instruc-
tions. Extracted RNA was eluted in 35 μL of RNase-free 
water and stored at –70ºC. cDNA was reverse transcribed 
using 9 μL of eluted RNA (10 pg–5 μg) in an initial 12-μL 
reaction mixture containing 50 ng of random hexamers and 
0.5 mmol/L of dNTPs. After incubation at 65ºC for 5 min 
to denature the RNA, 10 mmol/L of dithiothreitol, 5× Syn-
thesis Buffer, 40 U of RNaseOUT, and 15 units of Ther-
moscript RT were added on ice (Invitrogen, Carlsbad, CA, 
USA). Reaction mixtures were incubated in thermocycler 
at 25ºC for 10 min, followed by 50ºC for 30 min. cDNA 
was stored at –20ºC.
PCR
Primers amplifying 7b (736 bp), membrane protein 
(575 bp), polymerase (386 bp), and spike-NSP3 (1,017 bp) 
(Figure 3) were designed based on available feline coro-
navirus sequence (1,12,13). PCR was performed by using 
2 μL of cDNA in a 50-μL reaction containing 50 mmol/L 
KCl, 10 mmol/L Tris-HCl (pH 8.3), 1.5 mmol/L MgCl2, 
0.25 mmol/L concentrations of dNTPs (dATP, dCTP, 
dGTP, and dTTP), 2 mmol/L concentrations of each prim-
er, and 2.5 units of Platinum Taq DNA polymerase (Invit-
rogen). PCR was conducted on a geneAmp PCR system 
9700 thermocycler (Applied Biosystems, Foster City, CA, 
USA) with the following touchdown conditions: 2 min at 
94ºC then a touchdown, always starting with 20 sec at 94ºC, 
then 30 sec at 60ºC (3 cycles), 58ºC (5 cycles), 56ºC (5 
cycles), 54ºC (5 cycles), 52ºC (22 cycles), and then 1 min 
at 72ºC for extension, and with a final extension at 72ºC for 
7 min and a hold at 4ºC. PCR products were visualized by 
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Figure 2. A) Histopathologic and 
immunohistochemical (IHC) results 
from 23 necropsied cats positive 
for antibodies against feline 
coronavirus. Liver, lung, spleen, 
colon, jejunum, stomach, heart, 
kidney, lymph node were evaluated 
by IHC. Feline infectious peritonitis 
(FIP) cases are highlighted in 
gray. Pos, positive; Neg, negative; 
ND, not done. B) Representative 
tissues from cat no. FCA-4653, 
spleen (histopathologic) showing 
granuloma (arrow); magnification 
×20. C) Representative tissues 
from cat no. FCA-4590, small 
intestine (IHC); magnification ×20. 
D) Red staining indicates binding 
of coronavirus antibody (CoV p56, 
arrow); magnification ×100. 
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electrophoresis on a 1% agarose gel and primers and unin-
corporated dNTPs were removed by using Microcon YM 
(Millipore, Billerica, MA, USA).
Cloning and Sequencing
Representative PCR products were cloned and se-
quenced (Figure 3, panel B). Cloning was performed by 
using a TOPO-TA cloning kit (Invitrogen) according to the 
manufacturer’s instructions. Plasmid DNA was isolated 
from 1–47 clones from each reaction product (Agencourt 
CosMCPrep; Agencourt Bioscience Corporation, Bev-
erly, MA, USA). The presence of the correct sized insert 
was verified by restriction enzyme digestion (EcoRI), and 
sequences were obtained from clones with the correct in-
sert by using standard ABI BigDye terminator reactions 
(Applied Biosystems). Anticontamination measures were 
taken at all steps of reverse transcription–PCR (RT-PCR) 
amplification and post-PCR processing.
Phylogenetic Analysis
Sequences from pol 1a, spike-NSP3, membrane, and 
NSP7b were analyzed separately. Nucleotide sequences 
were compiled and aligned for subsequent phylogenetic 
analysis by using ClustalX (25) and verified visually (26). 
Analyses involved producing a phylogenetic tree of vi-
ral gene sequences based upon the following approaches: 
minimum evolution, maximum parsimony, and maximum 
likelihood in PAUP (27). Modeltest was used to estimate 
the optimal model of sequence evolution, and these settings 
were incorporated into subsequent analyses (28). Minimum 
evolution trees were constructed from models of substitu-
tion specified by Modeltest, with starting trees obtained 
by neighbor joining followed by application of a tree-bi-
section-reconnection (TBR) branch-swapping algorithm 
during a heuristic search for the optimal tree. Maximum 
parsimony analysis employed a heuristic search of start-
ing trees obtained by stepwise addition followed by TBR. 
Maximum-likelihood parameters specified by Modeltest 
selected the general time-reversible model of substitution, 
included empirical base frequencies, and estimated rate 
matrix and corrected for among-site rate variation (gamma 
distribution). A bootstrap analysis using 1,000 iterations 
was performed for maximum parsimony and minimum 
evolution and 100 iterations by using the nearest neigh-
bor interchange branch-swapping algorithm for maximum 
likelihood. Amino acid residue alignments were generated 
using MacClade 3.05 (26) and ClustalX (www.softpedia.
com/get/Science-CAD/Clustal-X.shtml).
Variable sites and parsimoniously informative sites 
were computed in MEGA version 3.0 (29). Pairwise com-
parisons of genetic distances were performed in PAUP and 
the mean and range of genetic distances were calculated in 
Excel (Microsoft, Redmond, WA, USA). The sequences of 
FCoV pol 1a, membrane, NSP 7b, and spike-NSP3 were 
deposited in GenBank under accession nos. EU663755–
EU664317.
Results
During 2004–2006, fifty-six domestic cats with sus-
pected FIP or exposure to infected FIP cats from Maryland 
farms and veterinary hospitals were sampled (online Ap-
pendix Table 1). All samples producing RT-PCR products 
were from cats positive for antibodies against FCoV (titers 
>25). Thirty-six sampled cats were from the Weller farm 
where several individual cats were sampled once per year 
for the 3-year study period. Healthy and recently deceased 
or euthanized cats were included from the Ambrose farm (n 
= 7), Palmer Veterinary Hospital (n = 3), Frederick County 
Animal Shelter (n = 7), Seymour farm (n = 1), and the New 
Market Animal Hospital (n = 2). Fca-4590 from the Weller 
farm is an important FIP case because samples were ob-
tained on May 20, 2004, when the cat was clinically healthy 
(predisease) and again on December 22, 2004, when FIP 
developed in the cat and it died (postdisease).
Necropsies were performed on 23 cats that died or 
were euthanized due to suspected FIP. Most of the necrop-
sied cats were FCoV antibody positive (online Appendix 
Table 1). Eight cats were classified as FIP cases based on 
histopatholgic findings (Fca-4549, Fca-4566, Fca-4590, 
Fca-4618, Fca-4653, Fca-4662, Fca-4663, and Fca-4664) 
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Figure 3. A) Feline coronavirus genome indicat-
ing PCR products obtained (bars). Structural 
proteins are shaded in dark gray; nonstructural 
proteins are shaded in light gray. B) Forward and 
reverse primers used to amplify virus segments 
are listed in 5′ → 3′ orientation. The number of 
source cats and cloned sequences generated 
from feline infectious peritonitis (FIP) cases and 
feline enteric coronavirus (FECV) asymptomatic 
cats are presented. Pol, polymerase; NSP, 
nonstructural protein; FIPV, feline infectious 
peritonitis virus.
Feline Infectious Peritonitis Virus
(Figure 2; online Appendix Table 1). The presence of pyo-
granulomatous lesions at histology evaluation was suffi-
cient for designation of an FIP case. Additionally, 5 of the 
8 FIP cases were evaluated by IHC testing. Multiple tissues 
were positive by IHC in each of these cats. One cat (Fca-
4561) was IHC positive only in the jejunum and negative 
by histopathologic analysis on all tissues, therefore it was 
classified as FECV asymptomatic. The FCoV-seropositive 
necropsied cats with no characteristic FIP histopathologic 
changes and IHC lesions were classified as FECV asymp-
tomatic (online Appendix Table 1; Figure 2). Healthy cats 
were classified as FECV asymptomatic if they had normal 
results on physical examinations, were FCoV antibody 
positive (titer >25) but not lymphopenic (<1.5 cells/μL), 
or were monitored until 2007 and known to be free of FIP 
disease (online Appendix Table 1).
RT-PCR was attempted with 4 primer pairs designed 
from FCoV genes for all cats (Figure 3, panel B). Of the 
82 samplings from 56 cats, 42 samplings amplified virus 
with at least 1 primer pair yielding a 51% rate of recovery 
of viral sequence (online Appendix Table 1). From 8 cats 
with clinical FIP and 23 FECV-asymptomatic cats, ampli-
fication from the 4 viral regions produced 735 cloned viral 
gene segments that resulted in 501 unique gene sequences 
(online Appendix Table 2, available from www.cdc.gov/
EID/content/15/9/1445-appT2.htm; Figure 3, panel B).
Phylogenetic analysis of the cloned virus sequenc-
es from 3 Maryland locales sampled during 2004–2006 
showed specific patterns of viral dynamics. First, gene se-
quences from healthy cats infected with FECV displayed a 
monophyletic cluster pattern that was generally distinctive 
from cats diagnosed with FIP in the membrane, NSP 7b, 
and spike-NSP3 gene segments (Figure 4). For example, 
every FCoV gene sequence for the membrane gene from 
FIP cases fell within a major cluster consisting of 3 prin-
cipal clades (Figure 4). By contrast, 127/154 (82%) virus 
gene sequences from FECV-asymptomatic cats sorted in 2 
separate clades that were distinct (100 bootstrap statistical 
support) from the viral gene sequences of FIP cases (Figure 
4). Similar reciprocal monophyly of 140 NSP7b sequences 
was obtained for FIP cases versus FECV-asymptomatic 
cats (Figure 4). A consistent disease driven phylogeograph-
ic sorting was also observed for the 1,017-bp sequence 
spanning the spike-NSP3 genes, albeit with less statistical 
resolution, likely because of evolutionary constraints on 
gene divergence in this region (Figure 4). Together the re-
markable reciprocal monophyly in these 3 genes supports 
the predictions of the circulating virulent-avirulent strain 
hypothesis illustrated in Figure 1.
Samples from 1 cat, Fca-4590, were particularly in-
formative. The virus was isolated from the cat predisease, 
and then again 7 months later postdisease. Fca-4590 was 
asymptomatic but infected with FECV in May 2004. FCoV 
sampling from that month showed strong (high bootstrap) 
affiliation with the FECV-asymptomatic clades for the 
membrane and the NSP7b genes. However, virus isolated 
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Figure 4. Maximum-likelihood (ML) phylogenetic tree of unique 
sequences from 3 feline coronavirus (FCoV) genes, membrane, 
NSP 7b, and spike-NPS3 (see Figure 3), showing monophyly 
correlating to disease status. Cloned sequences from feline 
infectious peritonitis (FIP) cases are shown in red, feline enteric 
coronavirus (FECV) asymptomatic cats are shown in blue, and 
FCoV virulent strain from Aju-92 (cheetah) is in green. Shown 
above are membrane 575-bp sequences (ML –ln L = 3086.20787 
best tree found by maximum parsimony [MP] tree: length = 493, 
CI = 0.551724, RI = 0.0926505); additional sequences are shown 
in an online expanded version of this figure, available from www.
cdc.gov/EID/content/15/9/1445-F4.htm. The number of FIP cases 
and FECV-asymptomatic cats and number of cloned sequences 
is indicated in parenthesis. Each sequence is labeled as follows: 
source farm (W, Weller Farm; F, Frederick Animal Shelter; S, 
Seymour Farm; M, Mount Airy Shelter; A, Ambrose Farm), 4-digit 
cat identification number, tissue source (fe, feces; af, ascites fluid; 
co, colon; li, liver; sp, spleen; in, intestine; je, jejunum; ln, lymph 
node), 2-digit year (eg., 04 = 2004), and number of clones for each 
sequence. Bootstrap values are shown (MP/minimum evolution/
ML) above branches. Where ML tree was congruent with MP 
tree, branch lengths are indicated below branches; the number of 
homoplasies is in parenthesis after the branch length. Number of 
cats and number of clones assessed are listed in Figure 3, panel B. 
Virus sequence obtained from cat no. 4590 in May 2004 and at the 
time of death due to FIP in December 2004 is indicated by box. The 
4590-transitional individual serial samples are indicated with open 
circles (first sample) and solid circles (second sample). Scale bar 
indicates substitutions/site.
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7 months later in December 2004 after FIP developed in 
Fca-4590 fell within the FIP-case clades (also with high 
bootstrap), and was indistinguishable from FCoV isolated 
from other cats with FIP. This finding suggested that the 
pathogenic FIP-case type of FCoV infected this cat subse-
quent to its infection with an avirulent FECV and appar-
ently replaced it.
Tissue-specific differentiation within each cat was 
minimal (Figure 4). By contrast, there were notable locale-
specific distinctions within the sick and healthy cats (Fig-
ure 4). For example, the FECV strains in asymptomatic cats 
from the Weller household were associated together in a 
major FECV subclade; strains in cats from the Frederick 
Animal Shelter were classified in a different subclade, nest-
ed within the FECV-asymptomatic clade (Figure 4). The 
archival FCoV virulent strain (Aju-92), isolated from chee-
tahs in Oregon in 1982 (30), defined a phylogenetic lineage 
distinctive from the FIP and FECV-asymptomatic clades 
resolved in the Maryland domestic cats (Figure 4).
Nucleotide sequences of membrane and NSP 7b 
generated in this study were translated to amino acid se-
quences (online Appendix Figure 1, available from www.
cdc.gov/EID/content/15/9/1445-appF1.htm). Relative to 
pathogenesis, 5 informative amino acid sites were found 
in the membrane protein at positions 108, 120, 138, 163, 
and 199 (based on reference sequence for TGEV GenBank 
no. NP058427) (22), giving rise to 6 composite genotypes 
potentially diagnostic of FIP cases versus FECV-asymp-
tomatic cats (online Appendix Table 2). Among the 8 cats 
with FIP, 19 FECV-asymptomatic cats, and 1 cheetah with 
FIP, 6 composite genotypes were identified based on these 
5 diagnostic sites (online Appendix Table 2).
All domestic cats with FIP diagnosed by pathologic 
or immunohistochemical changes displayed the amino acid 
signature of either YIVAL (I) or YIIAL (II); infected cats 
without clinical FIP had the HIIVI (III), HIIVL (IV), HVI-
AL (V), YVVAL (VI), or YIVAL (I) haplotype. No FIP 
cases had haplotype III, IV, V, or VI, whereas 3 FECV-
asymptomatic cats carried the YIVAL signature found pre-
dominately in FIP cases (Fca-4594, 4624, and 4657; online 
Appendix Table 2). Of these, 2 cats (4624 and 4657) were 
euthanized at the time of sampling (all euthanized FECV-
asymptomatic cats are highlighted in light green in online 
Appendix Table 2); therefore, whether clinical FIP would 
have later developed in these cats is unknown. The other 
exception, cat 4594, was sampled twice (in 2004 and again 
in 2006); the switch in genetic signature from YIVAL in 
2004 to HIIVI in 2006 may indicate that this cat was able 
to clear a virulent FIPV strain after the 2004 sampling 
and become reinfected with an avirulent strain by 2006. 
Although a strong phylogenetic signal differentiating FIP 
cases from FECV-asymptomatic cats was seen in NSP 7b 
(Figure 4), no diagnostic amino acid changes specific to 
FIP cases vs. FECV-asymptomatic controls were found in 
the NSP 7b nucleotide or amino acid alignments. In con-
trast to the monophyletic findings in the membrane, NSP 
7b, and spike-NSP3 genes, cloned viral sequences of pol 
1a, were paraphyletic in terms of disease phenotype (on-
line Appendix Figure 2, available from www.cdc.gov/EID/
content/15/9/1445-appF2.htm).
Discussion
Infection with FCoV is common in cats throughout the 
world, although in most cats the virus causes no clinical 
signs. However, in some cats, FCoV infection is associated 
with the development of the progressive and fatal disease 
manifestation of FIP. This disease is among the most seri-
ous viral infections in cats, not only because of its fatal na-
ture, but also because of the difficulties in diagnosing FIP 
antemortem and controlling the spread of FCoV. We have 
presented a molecular virologic study of naturally occurring 
FCoV infection and phylogenetic analysis of the cloned vi-
rus sequences obtained from the membrane, NSP 7b, spike-
NSP3, and pol 1a genes isolated from domestic cats located 
in Maryland households infected with FCoV during 2004–
2006. We observed predominately monophyletic clustering 
of strains correlating with disease phenotype in membrane 
and NSP 7b genes consistent with the circulating virulent/
avirulent strain hypothesis of FIP pathogenesis, which calls 
into question the in vivo mutation hypothesis.
The amino acid alignments presented in online Ap-
pendix Figure 1 clearly demonstrate that in the FIPV cases 
included in this study the genotypes correlated with disease 
phenotype are ancestrally derived and not the result of a few 
de novo mutations. Given the clear genetic differentiation 
between viruses from FIP cases and FECV asymptomatic 
cats in multiple gene segments, we infer that cats become 
reinfected with new strains of FCoV from external sources, 
rather than by in vivo mutations. Cats in our study were 
not co-infected with multiple strains of FECV and FIPV 
at the same time and were generally infected with one pre-
dominant virus strain. Two exceptions to this finding in our 
study were cats with cases of FIPV (Fca-4662 and 4664) 
that from which distinct gastrointestinal (feces or intestine) 
and systemic (liver and/or ascites fluid) viral isolates were 
obtained, which indicates that in vivo superinfection does 
occur (Figure 4; online Appendix Table 2).
A role of the membrane protein in FIP pathogenesis 
seems likely, given its known functions in other coronavi-
ruses. The membrane protein is the most abundant struc-
tural protein with important functions in virus budding 
and with cell-mediated host immunity (31). The specific 
functions of the membrane protein amino acid sequences 
have been determined in severe acute respiratory syndrome 
(SARS)–CoV (32). Aligning the sequences from this study 
with SARS-CoV, the first diagnostic amino acid site 108 
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aligns to a site just upstream from the second transmem-
brane helix (online Appendix Figure 1). A tyrosine at posi-
tion 108, which is found in all FIPV biotypes and shared 
among SARS-CoV, has a neutral polarity (in contrast to a 
histidine there, found in most FECV biotypes, which have 
a positive polarity) and may play a role in the stability of 
the virus within the membrane. Site 120 aligns within the 
third transmembrane helix, site 138 aligns just downstream 
to the transmembrane helice, site 163 aligns within the C-
terminus, which projects inside the virus particle, and site 
199, also within the C-terminus domain, aligns within a de-
fined SARS-immunodominant epitope (32) (Figure 5).
The demonstration of 6 naturally occurring composite 
genotypes based on 5 variable sites in the membrane pro-
tein amino acid alignment that are highly correlative with 
disease phenotype (online Appendix Table 2) offers specific 
opportunities for developing diagnostics and for the preven-
tive management of this disease. By extending this study to 
additional cat populations in disparate geographic locations, 
designing chimeric FCoV challenge experiments, and inves-
tigating host genetic correlations with pathogenesis, we will 
be able to further discern the causative factors in FIP patho-
genesis. Fca-4594, which was infected with the disease-
associated genotype composite without succumbing to FIP, 
suggests additional requirements for viral pathogenesis. As 
has been suggested in the outbreak of FIP in a colony of cap-
tive cheetahs (33), host immune genetics may play a role.
Both the viral strain and host immune genes contrib-
ute to disease progression and virus-related death, such as 
AIDS progression in HIV infection. With the recent pub-
lication of the full cat genome sequence (34) and the viral 
genotype composites described here, new genomic tools 
are now available to proceed with both viral and host ge-
netic association studies in the pathogenesis in FCoV infec-
tion, a model for coronavirus infection in humans, such as 
SARS-CoV.  
Acknowledgments
We thank Linda Rawls, Beth Weller, and Frederick County 
Animal Shelter for help with sample collection; Bailey Kessing 
and Nicole Crumpler for sample database management; Dahlem 
Smith for histopathologic evaluation; and James Evermann for 
immunohistochemical assistance.
This study was supported in part by the National Cancer 
Institute, National Institutes of Health, under contract N01-CO-
12400; and the Intramural Research Program of the National In-
stitutes of Health, National Cancer Institute, Center for Cancer 
Research.
Dr Brown completed this work while a member of the Labo-
ratory of Genomic Diversity at the National Cancer Institute. Cur-
rently, she is a postdoctoral research fellow at University College 
Dublin Veterinary Sciences Centre, Ireland. Her research interests 
include infectious disease studies in the cat animal model.
References
  1.  Addie DD. Clustering of feline coronaviruses in multicat house-
holds. Vet J. 2000;159:8–9. DOI: 10.1053/tvjl.1999.0429
  2.  Addie DD, Jarrett O. A study of naturally occurring feline coronavi-
rus infections in kittens. Vet Rec. 1992;130:133–7. 
  3.  Kennedy M, Citino S, McNabb AH, Moffatt AS, Gertz K, Kania S. 
Detection of feline coronavirus in captive Felidae in the USA. J Vet 
Diagn Invest. 2002;14:520–2. 
  4.  Pedersen NC. A review of feline infectious peritonitis virus infection: 
1963–2008. J Feline Med Surg. 2009;11:225–58. DOI: 10.1016/ 
j.jfms.2008.09.008
  5.  Foley JE, Poland A, Carlson J, Pedersen NC. Risk factors for fe-
line infectious peritonitis among cats in multiple-cat environments 
with endemic feline enteric coronavirus. J Am Vet Med Assoc. 
1997;210:1313–8. 
  6.  Pedersen NC, Evermann JF, McKeirnan AJ, Ott RL. Pathogenicity 
studies of feline coronavirus isolates 79-1146 and 79-1683. Am J Vet 
Res. 1984;45:2580–5. 
  7.  de Groot RJ. Feline infectous peritonitis. In: Siddell SG, editor. The 
Coronoviridae. New York: Plenum Press; 1995. p. 293–309.
  8.  Weiss RC, Scott FW. Pathogenesis of feline infectious peritonitis: 
nature and development of viremia. Am J Vet Res. 1981;42:382–
90. 
  9.  Kipar A, Kohler K, Leukert W, Reinacher M. A comparison of lym-
phatic tissues from cats with spontaneous feline infectious perito-
nitis (FIP), cats with FIP virus infection but no FIP, and cats with 
no infection. J Comp Pathol. 2001;125:182–91. DOI: 10.1053/
jcpa.2001.0501
10.  Kipar A, Meli ML, Failing K, Euler T, Gomes-Keller MA, Schwartz 
D, et al. Natural feline coronavirus infection: differences in cytokine 
patterns in association with the outcome of infection. Vet Immu-
nol Immunopathol. 2006;112:141–55. DOI: 10.1016/j.vetimm. 
2006.02.004
 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 15, No. 9, September 2009 1451 
Figure 5. Diagram of membrane protein 
containing 3 transmembrane helices, 
an external N terminus and an internal 
carboxy terminus. Approximate position 
of 5 variable diagnostic amino acid sites 
(see Table 2) as determined by sequence 
comparison to severe acute respiratory 
syndrome coronavirus (32). Amino acid 
residue, polarity, and hydrophobicity or 
hydropholicity is stated.
RESEARCH
11.  Hunziker L, Recher M, Macpherson AJ, Ciurea A, Freigang S, Hen-
gartner H, et al. Hypergammaglobulinemia and autoantibody induc-
tion mechanisms in viral infections. Nat Immunol. 2003;4:343–9. 
DOI: 10.1038/ni911
12.  Poland AM, Vennema H, Foley JE, Pedersen NC. Two related 
strains of feline infectious peritonitis virus isolated from immuno-
compromised cats infected with a feline enteric coronavirus. J Clin 
Microbiol. 1996;34:3180–4. 
13.  Vennema H, Poland A, Foley J, Pedersen NC. Feline infectious peri-
tonitis viruses arise by mutation from endemic feline enteric corona-
viruses. Virology. 1998;243:150–7. DOI: 10.1006/viro.1998.9045
14.  Rottier PJ, Nakamura K, Schellen P, Volders H, Haijema BJ. Ac-
quisition of macrophage tropism during the pathogenesis of feline 
infectious peritonitis is determined by mutations in the feline coro-
navirus spike protein. J Virol. 2005;79:14122–30. DOI: 10.1128/
JVI.79.22.14122-14130.2005
15.  Stoddart CA, Scott FW. Intrinsic resistance of feline peritoneal mac-
rophages to coronavirus infection correlates with in vivo virulence. 
J Virol. 1989;63:436–40. 
16.  Haijema BJ, Volders H, Rottier PJ. Switching species tropism: an 
effective way to manipulate the feline coronavirus genome. J Virol. 
2003;77:4528–38. DOI: 10.1128/JVI.77.8.4528-4538.2003
17.  Can-Sahna K, Soydal Ataseven V, Pinar D, Oguzoglu TC. The de-
tection of feline coronaviruses in blood samples from cats by mRNA 
RT-PCR. J Feline Med Surg. 2007;9:369–72. DOI: 10.1016/j.
jfms.2007.03.002
18.  Dye C, Siddell SG. Genomic RNA sequence of feline coronavi-
rus strain FCoV C1Je. J Feline Med Surg. 2007;9:202–13. DOI: 
10.1016/j.jfms.2006.12.002
19.  Hartley O, Klasse PJ, Sattentau QJ, Moore JP. V3: HIV’s switch-hit-
ter. AIDS Res Hum Retroviruses. 2005;21:171–89. DOI: 10.1089/
aid.2005.21.171
20.  Ballesteros ML, Sanchez CM, Enjuanes L. Two amino acid changes 
at the N-terminus of transmissible gastroenteritis coronavirus spike 
protein result in the loss of enteric tropism. Virology. 1997;227:378–
88. DOI: 10.1006/viro.1996.8344
21.  Saif LJaS. K. Transmissible gastroenteritis virus and porcine respi-
ratory coronavirus. In: Zimmerman JJ, editor. Diseases of swine. 9th 
ed. Ames (IA): Iowa State University Press; 2006. p. 489–516.
22.  Sanchez CM, Izeta A, Sanchez-Morgado JM, Alonso S, Sola I, Bal-
asch M, et al. Targeted recombination demonstrates that the spike 
gene of transmissible gastroenteritis coronavirus is a determinant of 
its enteric tropism and virulence. J Virol. 1999;73:7607–18. 
23.  Mongkolsapaya J, Dejnirattisai W, Xu XN, Vasanawathana S, 
Tangthawornchaikul N, Chairunsri A, et al. Original antigenic sin 
and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat 
Med. 2003;9:921–7. DOI: 10.1038/nm887
24.  Anishchenko M, Bowen RA, Paessler S, Austgen L, Greene IP, 
Weaver SC. Venezuelan encephalitis emergence mediated by a phy-
logenetically predicted viral mutation. Proc Natl Acad Sci U S A. 
2006;103:4994–9. DOI: 10.1073/pnas.0509961103
25.  Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG. 
The CLUSTAL_X windows interface: flexible strategies for mul-
tiple sequence alignment aided by quality analysis tools. Nucleic 
Acids Res. 1997;25:4876–82. DOI: 10.1093/nar/25.24.4876
26.  Maddison DRaM. W.P. MacClade 3.05. Sunderland (MA): Sinauer; 
1995.
27.  Swofford DL. PAUP*: Phylogenetic Analysis Using Parsimony 
(*and other methods). Sunderland (MA): Sinauer; 2002.
28.  Posada D, Crandall KA. MODELTEST: testing the model of 
DNA substitution. Bioinformatics. 1998;14:817–8. DOI: 10.1093/
bioinformatics/14.9.817
29.  Kumar S, Tamura K, Nei M. MEGA3: Integrated software for Mo-
lecular Evolutionary Genetics Analysis and sequence alignment. 
Brief Bioinform. 2004;5:150–63. DOI: 10.1093/bib/5.2.150
30.  Pearks Wilkerson AJ, Teeling EC, Troyer JL, Bar-Gal GK, Roelke M, 
Marker L, et al. Coronavirus outbreak in cheetahs: lessons for SARS. 
Curr Biol. 2004;14:R227–8. DOI: 10.1016/j.cub.2004.02.051
31.  Rottier PJ. The coronavirus membrane glycoprotein. In: Siddell 
SG, editor. The Coronaviridae. New York: Plenum Press; 1995. p. 
115–40.
32.  He Y, Zhou Y, Siddiqui P, Niu J, Jiang S. Identification of immu-
nodominant epitopes on the membrane protein of the severe acute 
respiratory syndrome-associated coronavirus. J Clin Microbiol. 
2005;43:3718–26. DOI: 10.1128/JCM.43.8.3718-3726.2005
33.  Heeney JL, Evermann JF, McKeirnan AJ, Marker-Kraus L, Roelke 
ME, Bush M, et al. Prevalence and implications of feline coronavi-
rus infections of captive and free-ranging cheetahs (Acinonyx juba-
tus). J Virol. 1990;64:1964–72. 
34.  Pontius JU, Mullikin JC, Smith DR, Lindblad-Toh K, Gnerre S, 
Clamp M, et al. Initial sequence and comparative analysis of the cat 
genome. Genome Res. 2007;17:1675–89. DOI: 10.1101/gr.6380007
Address for correspondence: Meredith A. Brown, Laboratory of Genomic 
Diversity, National Cancer Institute, Frederick, MD 21702, USA; email: 
brownmer@gmail.com
1452 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 15, No. 9, September 2009
The opinions expressed by authors contributing to this journal do 
not necessarily reflect the opinions of the Centers for Disease Con-





Borna disease virus was named after the town of Borna in Saxony, southeastern Germany, where in 1885 many 
horses in a German cavalry regiment died of a fatal neurologic disease. The ill horses exhibited abnormal 
behavior—running about excitedly, walking into walls, being unable to chew food. A similar disease had been 
observed in horses, sheep, and cattle for more than 100 years. The causative agent was later found to be a negative-
stranded RNA virus, which may also be a human pathogen.
Source: Carabone KM. Borna disease virus and its role in neurobehavioral disease. Washington: ASM Press; 2002.
